Total Funding
73
54
Total FundingSeries B raised
Growth Score
-17 pts
Heat Score
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
26367
Invenra operates as a biotechnology company focused on early stage drug discovery.
Richard R. Lesniewski: Board of DirectorsPast Role: Abbott, Held Multiple Leadership Positions- Jonathan Davis: VP of Innovation and StrategyPast Role: Bristol-Myers Squibb, Protein Design & Principal Scientist
About the Company
Invenra is focused on discovering the next generation of best-in-class biologics, with an emphasis on antibodies and their derivatives. The company's proprietary technology combines the cell-free expression of full-length antibodies and extreme miniaturization, enabling the screening of unprecedented numbers of full-length antibodies in
phenotypic assays. Invenra touts a broad scientific foundation and a team of scientists with deep expertise in key areas ranging from genomics to biochemistry to bioengineering. Their background is well balanced between cutting edge basic research and commercial products and services.
The company was established in 2011 and is based in Madison, Wisconsin, United States.
